Effects of exenatide on postprandial vascular endothelial dysfunction in type 2 diabetes mellitus

Table 3 Correlation coefficients between dL_RHI and clinical markers of glycemia and various nonglycemic metabolic variables

	dAUC _glucose	dAUC _IRI	dAUC _TG	dAUC _HDL	dAUC _LDL	dCV _glucose	dCV _IRI	dCVTG _TG	dCV _HDL	dCV _LDL
dAUC_IRI	−0.39
dAUC_TG	−0.02	0.17
dAUC_HDL	0.40	0.33	-.0.06
dAUC_LDL	−0.10	0.60*	0.04	0.35
dCV_glucose	0.06	0.39	−0.24	−0.12	0.50
dCV_IRI	−0.43	0.58*	0.29	0.02	0.37	0.35
dCV_TG	0.39	0.09	−0.06	−0.13	0.27	0.37	0.14
dCV_HDL	0.44	−0.26	−0.23	−0.46	−0.09	−0.30	0.01	0.64*
dCV_LDL	0.35	0.35	−0.22	−0.42	−0.24	−0.24	−0.60*	0.14	0.38
dL_RHI	−0.37	0.33	0.24	0.16	−0.17	−0.19	0.29	−0.73**	−0.61*	−0.33

Data are results of Spearman rank correlation. *P < 0.05, **P < 0.01.
Abbreviations: dAUC change in the area under the curve, IRI Immunoreactive insulin, LDL low-density lipoprotein cholesterol, HDL high-density lipoprotein cholesterol, TG triglyceride, dCV change in the coefficient of variation, dL_RHI change in the natural logarithmic scaled reactive hyperemia index.

ISSN: 1475-2840